產(chǎn)品名稱：Everolimus 產(chǎn)品貨號(hào)：Affix AF3029 產(chǎn)品規(guī)格：5 mg Technical Data Chemical Name 3,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine, rapamycin deriv.; 40-O-(2-Hydroxyethyl)rapamycin; 42-O-(2-Hydroxy)ethyl rapamycin; Certican; RAD; RAD 001; SDZ-RAD; XIENCE V Biological Description Everolimus is a macrolide derived from Rapamycin, and shown to inhibit cell proliferation induced by growth factors. Macrolides belong to a group of antibiotics that bind to the 50S ribosomal subunit and inhibit protein synthesis. Studies indicate that Everolimus is an mTOR inhibitor that displays high affinity toward the intracellular receptor FKBP12. The Everolimus-FKBP12 complex decreases the activity of the S6K1 and 4EBP by binding to mTOR Molecular Weight 958.2 daltons. Molecular Formula C53H83NO14 Solubility Soluble in DMSO at 100 mg/mL; ethanol at 100 mg/mL; Not soluble in water. Purity >99 % Storage instructions Up to one week at 4°C or six months at -20°C. CAS No. 159351-69-6 References Anandappa, G., et al. 2010. Cancer Manag Res. 2: 61-70.
滬公網(wǎng)安備 31011002002623號(hào)
